beta Amyloid anticorps

N° du produit ABIN1580412

Cet anticorps anti-beta Amyloid est un anticorps Souris Monoclonal détectant beta Amyloid dans WB, IHC, IF et ICC. Adapté pour Humain.

Aperçu rapide pour beta Amyloid anticorps (ABIN1580412)

Antigène: beta Amyloid (Abeta) (Amyloid beta (Abeta))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp beta Amyloid est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC)

Clone: AB9

Détail du produit anti-beta Amyloid anticorps

Purification: affinity purified antibody

Isotype: IgG2a

Information d'application

Indications d'application: The antibody solution can be used at dilutions of 1:1,000 or higher in immunofluorescence experiments. In western blotting using chemiluminescence it can be used at dilutions of 1:1,000-2,000.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4°C short term or -20°C long term.

Détails sur beta Amyloid

Antigène: beta Amyloid (Abeta) (Amyloid beta (Abeta))

Sujet: Alzheimer's disease (AD) is a serious and common age related dementia which is characterized by the formation of senile plaques and neurofibrillary tangles. Senile plaques are extracellular accumulations of insoluble proteins found in cortical regions. A major component of senile plaques is beta,-amyloid, a.k.a. Abeta, a peptide predominantly of 42 or 40 amino acids. The Abeta, peptide is derived from a section of the membrane spanning domain and the immediate extracellular region of a much larger protein called the amyloid precursor protein (APP). This is an abundant protein of poorly understood function. The Abeta, peptides are generated by the activity of proteases called secretases, specifically the beta, and gamma, secretases. Certain mutations in the APP gene are associated with familial forms of AD, as are mutations in the genes encoding proteins forming the secretase enzymes, in line with the hypothesis that Abeta, accumulation is central to the AD disease process. Our antibody recognizes amino acids 1-16 of the Abeta, peptide and works well on western blots, on formalin fixed sections and as a capture reagent in ELISA. It was originally developed in the Mayo Clinic in Jacksonville in the laboratory of Dr. Todd Golde.

Pathways: Inflammasome